Real-world data confirm elosulfase alfa improves endurance in MPS IVA patients across age groups, supporting its long-term effectiveness in enhancing mobility. bit.ly/4da1y4T #GIMO #Mucopolysaccharidosis #IVA #CrossSectional #MultivariateAnalysis #6MinuteWalkTest